Chances are you know someone who’s been diagnosed with prostate cancer. Other than skin cancer, prostate cancer is the most common cancer in American men. About 1 man in 8 will be diagnosed with prostate cancer during his lifetime.
Roughly 6 cases in 10 are diagnosed in men who are 65 or older, and it is rare in men under 40. The average age of men at diagnosis is about 66. Prostate cancer can be a serious disease, but most men diagnosed with prostate cancer do not die from it. According to the American Society of Clinical Oncology, for men with local or regional prostate cancer, 96 percent will live 15 years or longer. For that matter, there are approximately 3 million men currently living with the disease in the United States. Medical providers overseeing their ongoing care strive to optimize survivorship, helping each man improve his quality of life while continuing treatment and surveillance for recurrence.
The typical treatment for prostate cancer can involve surgery, radiation and hormone therapy. The overall goal is to decrease the male hormone testosterone to such a degree that, consequently, men begin to experience debilitating hot flashes. Just as in perimenopausal and menopausal women, hot flashes occur around the clock, and are often associated with drenching sweats and interrupted sleep. And, like women, men have been offered traditional medical treatments (sleep medications, anti-anxiety and anti-depressants drugs, all with side effects) while using personal remedies including fans, towels, frequent clothing changes, cranking up air conditioning, tossing off bed sheets, and guzzling cold water.
Flashing forward in time, and now there is a new option, one that taps into your own natural physiology. Presently, thousands of men and women have now discovered the Wave 2, Embr Labs’ thermal device. This new technology is a game-changer in the treatment of hot flashes. It not only provides relief for consumers seeking to reclaim control over their lives, but also gifts researchers with a new tool to use in the study of hot flashes.
We’re excited to share that in addition to our ongoing studies using the Wave 2 as a digital, non-medicinal solution for hot flashes in women (natural menopause, menopause induced by surgery and/or cancer treatment), we are also conducting milestone prostate cancer research which will empower men to achieve enhanced quality of life through better hot flash management. Medical care is now entering a new era of digital health, a concept embraced by consumers and providers, as well as clinical research scientists like Dr. Alicia Morgans, a nationally renowned prostate cancer survivorship expert, who noted in a recent study:
As Embr Labs’ clinical research team, we’re proud to stand at the forefront of historic, cutting-edge digital health science that is touching people’s lives through the Wave 2 technology. Our goal is to improve the quality of life for men and women, and support each person’s ability to both survive and, most importantly, thrive.